查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1543981

全球子宮內避孕器市場

Intrauterine Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球子宮內避孕器市場預計將達到 49 億美元

子宮內避孕器的全球市場預計 2023 年為 38 億美元，預計到 2030 年將達到 49 億美元，2023-2030 年分析期間複合年成長率為 3.8%。釋放荷爾蒙黃體素的子宮內避孕器是本報告分析的細分市場之一，預計複合年成長率為 3.4%，到分析期結束時將達到 34 億美元。分析期間，非荷爾蒙含銅子宮內避孕器市場的複合年成長率預計為 4.7%。

美國市場預計將成長10億美元，中國複合年成長率為3.6%

預計2023年美國子宮內避孕器市場規模將達10億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到7.766億美元，2023年至2030年複合年成長率為3.6%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.5% 和 3.2%。在歐洲，德國的複合年成長率預計為 3.9%。

全球子宮內避孕器市場—主要趨勢與促進因素總結

什麼是子宮內避孕器？

子宮內避孕器 (IUD) 是一種插入子宮以防止懷孕的小型 T 型避孕器。子宮內避孕器因其高效、方便和可逆性而成為長期避孕的流行選擇。子宮內避孕器可以是荷爾蒙型或非荷爾蒙型，前者會釋放少量黃體素以阻止排卵，後者通常由銅製成，為精子創造有毒環境。子宮內避孕器可以防止懷孕數年，對於尋求長期、無麻煩避孕的女性來說是一個有吸引力的選擇。子宮內避孕器可隨時取出，讓您立即恢復生育狀態，使其更具吸引力。隨著人們對子宮內避孕器益處的認知不斷提高，子宮內避孕器正在成為世界各地女性首選的避孕方法。

科技進步如何形塑子宮內避孕器市場？

技術進步正在顯著影響子宮內避孕器市場，特別是透過裝置設計、材料和安全功能方面的創新。現代子宮內避孕器旨在提高插入的舒適度和便利性，有些型號具有較小的尺寸和軟性材料，以減少插入過程中的不適。荷爾蒙子宮內避孕器的進步導致了能夠在較長時間內釋放較低劑量荷爾蒙的裝置的開發，從而在保持有效性的同時降低副作用的風險。此外，更安全的子宮內避孕器的引入，例如最大限度地降低穿孔和排放風險的子宮內避孕器，也有助於其廣泛使用。這些創新使子宮內避孕器更容易獲得並吸引更多女性，從而推動市場成長。

為什麼避孕護理中對子宮內避孕器的需求不斷增加？

由於人們越來越重視長期、可靠和低維護的避孕方法，避孕護理中對子宮內避孕器的需求正在增加。隨著女性尋求日常口服避孕藥和注射和貼片等短期避孕方法的替代品，子宮內避孕器提供了高效的解決方案，幾乎不需要持續維護。人們越來越認知到子宮內避孕器的長期健康益處，例如不干擾母乳哺育和可能降低某些癌症的風險，也推動了需求。此外，全球延遲生育的趨勢和計劃生育服務的日益普及也促進了子宮內避孕器的日益普及。隨著越來越多的女性優先考慮有效、方便和可逆的避孕措施，對子宮內避孕器的需求預計將繼續成長。

推動子宮內避孕器市場成長的因素有哪些？

子宮內避孕器市場的成長是由技術進步、消費者偏好變化和避孕方法選擇增加等多個因素所推動的。關鍵因素之一是子宮內避孕器設計和材料的進步，提高了舒適性、安全性和有效性，使其吸引了更廣泛的女性。人們越來越偏好長期、低維護的避孕方法，這也推動了需求，因為子宮內避孕器是每日或短期避孕方法的可靠替代品。計劃生育服務的增加和生殖健康的全球推廣進一步促進了市場的成長。此外，人們對子宮內避孕器的健康益處的認知不斷提高，包括其降低某些癌症風險的潛力及其對廣大女性的適用性，正在推動其採用。隨著這些趨勢的不斷發展，由於對有效、安全和方便的避孕解決方案的需求，子宮內避孕器市場預計將持續成長。

受訪企業範例（44家知名企業）

  • Allergan PLC
  • ANI Pharmaceuticals, Inc.
  • Bayer AG
  • Besins Healthcare（Monaco）
  • CooperSurgical, Inc.
  • Eurogine, SL
  • HLL Lifecare Ltd.
  • HRA Pharma
  • OCON Medical Ltd.
  • Pregna International Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP12831

Global Intrauterine Devices Market to Reach US$4.9 Billion by 2030

The global market for Intrauterine Devices estimated at US$3.8 Billion in the year 2023, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Nonhormonal Copper-Containing IUD segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 3.6% CAGR

The Intrauterine Devices market in the U.S. is estimated at US$1.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$776.6 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Intrauterine Devices Market - Key Trends & Drivers Summarized

What Are Intrauterine Devices and Why Are They a Popular Choice for Long-Term Contraception?

Intrauterine devices (IUDs) are small, T-shaped contraceptive devices that are inserted into the uterus to prevent pregnancy. They are a popular choice for long-term contraception due to their high effectiveness, convenience, and reversibility. IUDs can be hormonal or non-hormonal, with the former releasing small amounts of progestin to prevent ovulation and the latter, typically made of copper, creating an environment that is toxic to sperm. IUDs provide protection against pregnancy for several years, making them an attractive option for women seeking long-term, hassle-free contraception. Their ability to be removed at any time, allowing for a quick return to fertility, further enhances their appeal. As awareness of the benefits of IUDs increases, they are becoming a preferred contraceptive method among women worldwide.

How Are Technological Advancements Shaping the Intrauterine Devices Market?

Technological advancements are significantly shaping the intrauterine devices market, particularly through innovations in device design, materials, and safety features. Modern IUDs are being designed to offer improved comfort and ease of insertion, with some models featuring smaller sizes and flexible materials to reduce discomfort during placement. Advances in hormonal IUDs have led to the development of devices that release lower doses of hormones over longer periods, reducing the risk of side effects while maintaining efficacy. Additionally, the introduction of IUDs with enhanced safety profiles, such as devices that minimize the risk of perforation and expulsion, is contributing to increased adoption. These innovations are making IUDs more accessible and appealing to a broader range of women, driving growth in the market.

Why Is There an Increasing Demand for Intrauterine Devices in Contraceptive Care?

The demand for intrauterine devices is increasing in contraceptive care due to the growing emphasis on long-term, reliable, and low-maintenance birth control options. As women seek alternatives to daily oral contraceptives and short-term methods like injections or patches, IUDs offer a highly effective solution that requires little ongoing maintenance. The rising awareness of the long-term health benefits of IUDs, such as their non-interference with breastfeeding and their potential to reduce the risk of certain cancers, is also driving demand. Additionally, the global trend towards delaying childbirth and the increasing availability of family planning services are contributing to the growing popularity of IUDs. As more women prioritize effective, convenient, and reversible contraception, the demand for IUDs is expected to continue to rise.

What Factors Are Driving the Growth in the Intrauterine Devices Market?

The growth in the intrauterine devices market is driven by several factors related to technological advancements, changing consumer preferences, and the increasing availability of contraceptive options. One of the primary drivers is the advancement in IUD design and materials, which has improved the comfort, safety, and efficacy of these devices, making them more attractive to a wider range of women. The growing preference for long-term, low-maintenance contraception is also fueling demand, as IUDs offer a reliable alternative to daily or short-term methods. The increasing availability of family planning services and the global push for reproductive health and rights are further contributing to market growth, as more women gain access to contraceptive options. Additionally, the rising awareness of the health benefits of IUDs, such as their potential to reduce the risk of certain cancers and their suitability for a wide range of women, is driving adoption. As these trends continue to evolve, the intrauterine devices market is expected to experience sustained growth, driven by the need for effective, safe, and convenient contraceptive solutions.

Select Competitors (Total 44 Featured) -

  • Allergan PLC
  • ANI Pharmaceuticals, Inc.
  • Bayer AG
  • Besins Healthcare (Monaco)
  • CooperSurgical, Inc.
  • Eurogine, S.L
  • HLL Lifecare Ltd.
  • HRA Pharma
  • OCON Medical Ltd.
  • Pregna International Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intrauterine Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Long-Acting Reversible Contraception Spurs Adoption of Intrauterine Devices (IUDs)
    • Advancements in IUD Technology Propel Innovation in Contraceptive Solutions
    • Shift Towards Non-Hormonal and Hormonal IUDs Expands Market Opportunities
    • Increasing Use of IUDs in Family Planning Programs Globally
    • Role of IUDs in Reducing Unintended Pregnancies
    • Advancements in IUD Insertion Techniques and Device Safety Propel Market Growth
    • Emerging Markets Present New Opportunities for IUD Manufacturers
    • Rise in Demand for Targeted Temperature Management Spurs Adoption of Intravascular Temperature Management Devices
    • Advancements in Cooling and Heating Technology Propel Innovation in Temperature Management
    • Shift Towards Minimally Invasive Temperature Regulation Expands Market Opportunities
    • Increasing Use of Intravascular Temperature Management in Post-Cardiac Arrest Patients
    • Growing Importance of Hypothermia Induction in Trauma and Surgery
    • Advancements in Catheter-Based Cooling and Warming Systems Propel Market Growth
    • Push for Cost-Effective and Efficient Temperature Management Solutions
    • Role of Intravascular Temperature Management in Improving Patient Outcomes
    • Growing Focus on Patient Safety and Reducing Complications
    • Integration of Temperature Management Devices with Advanced Monitoring Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intrauterine Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intrauterine Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intrauterine Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Intrauterine Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hormonal Progestogen-Releasing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hormonal Progestogen-Releasing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hormonal Progestogen-Releasing IUD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nonhormonal Copper-Containing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Nonhormonal Copper-Containing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Nonhormonal Copper-Containing IUD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for 15 - 24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for 15 - 24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for 15 - 24 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for 25 - 34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for 25 - 34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for 25 - 34 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for 35 - 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for 35 - 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for 35 - 44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Above 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Above 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Above 44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Community Healthcare Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Community Healthcare Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Community Healthcare Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Intrauterine Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Intrauterine Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION